At the beginning of the pandemic, not much was known about how to treat COVID-19 patients, nor what additional medical complications could arise from this infection. The AMD reviewed the STGs for possible disease states and complications that could be of potential concern during the COVID-19 outbreak and the medicines used to treat these conditions. A list of potential medicines was drawn up and refined through expert reviews.
The NDoH drafted a COVID-19 guideline for South Africa, which was updated through a rapid review process. All documents were published on the NDoH website for easy access and transparency. Other critical items were added to the list where security of supply was at risk, especially from products that had to be imported. This added 367 items to the list that was managed by the COVID-19 task team, and dubbed the “COVID-19 Priority List”.